Empowering Patients On Choices for Renal Replacement Therapy (Aim 1)
NCT ID: NCT01952600
Last Updated: 2016-09-20
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
215 participants
OBSERVATIONAL
2013-06-30
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The outcomes most relevant to patients ("patient-centered") extend beyond those traditionally assessed in clinical research, with the relative importance varying across patient groups. A tailored decision aid based on these findings can improve patient decision-making processes regarding choice of dialysis modality.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Empowering Patients On Choices for Renal Replacement Therapy (Aim 3) (EPOCH-RRT)
NCT02488317
Empowering Patients on Choices for Renal Replacement Therapy (Aim 2)
NCT02440659
Assisted Peritoneal Dialysis: A Feasibility Study
NCT04319185
PINOT Follow-up Study in End-stage Kidney Disease
NCT01768624
Virtual Ward for Home Dialysis
NCT01912001
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Aim One of EPOCH-RRT identifies outcomes that are most important to different groups of advanced CKD and dialysis patients through qualitative methods applied for conducting in-depth interviews.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Chronic Kidney Disease (CKD)
Patients who have advanced chronic kidney disease, but are not currently on either hemodialysis (HD) or peritoneal dialysis (PD).
No interventions assigned to this group
Hemodialysis (HD)
Patients who have chronic kidney disease (CKD) and are currently on hemodialysis.
No interventions assigned to this group
Peritoneal Dialysis (PD)
Patients who have chronic kidney disease (CKD) and are currently on peritoneal dialysis.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Individuals with advanced chronic kidney disease or on dialysis (in-center, hemodialysis, or peritoneal dialysis) for at least three months.
Exclusion Criteria
* Individuals unable to provide informed consent.
* Individuals who do not have chronic kidney disease.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Michigan
OTHER
Henry Ford Health System
OTHER
National Kidney Foundation, United States
OTHER
American Association of Kidney Patients
OTHER
Patient-Centered Outcomes Research Institute
OTHER
Arbor Research Collaborative for Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Francesca Tentori, MD, MS
Role: PRINCIPAL_INVESTIGATOR
Arbor Research Collaborative for Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Arbor Research Collaborative for Health
Ann Arbor, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Arbor Research Collaborative for Health is committed to improving patient care through research that shapes medical policies and practice.
The University of Michigan Division of Nephrology is internationally recognized for its excellence in clinical care, rich educational offerings, and diverse research programs.
University of Michigan Center for Managing Chronic Disease aims to build the capacity for effective chronic disease prevention and management.
The National Kidney Foundation is a voluntary nonprofit health organization dedicated to preventing kidney disease.
The American Association of Kidney Patients is dedicated to improving the lives of kidney patients and their families by helping them deal with the physical, emotional, and social impact of kidney disease.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
110920130510
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.